Epigenomics AG Profile

5.16
USD 0.34  6.18%
4.19Last Month High 5.5 
5.16Trading Day  High 5.16 

Epigenomics AG Summary

Epigenomics AG (EPGNF) is traded on OTC Market in USA. It is located in Berlin, and employs 43 people. The company currently falls under 'Small-Cap' category with current market capitalization of 125.16 M. Epigenomics AG has 23.16 M outstanding shares. EPIGENOMICS AG BE has accumulated about 15 M in cash with (8.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check Epigenomics AG Probability Of Bankruptcy

Epigenomics AG Risk Profiles

Key Fundamentals

Epigenomics AG Against Markets

Current Ratings

Epigenomics AG 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
10 
Chance of
Financial Distress (0 to 100%)
< 45% 
Equity ratings for Epigenomics AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Epigenomics AG, a molecular diagnostics company, focuses on developing and commercializing in vitro diagnostic tests for the screening, early detection, and diagnosis of cancer in Germany and internationally. more
NameEpigenomics AG
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressBerlin,
ExchangeOTC Market
BenchmarkDOW
Websitewww.epigenomics.com
Contact Number49 30 243 450
CurrencyUSD - US Dollar

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Management

Epigenomics AG Corporate Management
Antje Zeise Manager Investor Relations
Guenther Reiter Member of the Supervisory Board
Ann Kessler Member of the Supervisory Board
Helge Lubenow Member of the Supervisory Board, Ph.D